Cardiac allograft vasculopathy intravascular ultrasound
Cardiac allograft vasculopathy Microchapters |
Differentiating Cardiac allograft vasculopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cardiac allograft vasculopathy intravascular ultrasound On the Web |
American Roentgen Ray Society Images of Cardiac allograft vasculopathy intravascular ultrasound |
FDA on Cardiac allograft vasculopathy intravascular ultrasound |
CDC on Cardiac allograft vasculopathy intravascular ultrasound |
Cardiac allograft vasculopathy intravascular ultrasound in the news |
Blogs on Cardiac allograft vasculopathy intravascular ultrasound |
Directions to Hospitals Treating Cardiac allograft vasculopathy |
Risk calculators and risk factors for Cardiac allograft vasculopathy intravascular ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Since the early manifestations of cardiac allograft vasculopathy (CAV) are confined to the arterial wall, use of intravascular ultrasound (IVUS) makes it particularly useful in assessing graft coronary arteries early after heart transplantation. Its relatively higher sensitivity in defining arterial wall changes has shed light on important advances in the understanding of the natural history, distribution, and morphology of CAV.